clinical trial data

Life sciences companies are in the crosshairs. As biopharma, medtech, and research organizations digitize discovery and clinical operations, attackers are following the data—intellectual property, clinical trial datasets, and increasingly, the AI systems shaping next-generation therapeutics. The stakes are high: interference can derail trials, distort research outcomes, and vaporize competitive advantage built over years. Insurance markets…